Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

CetuGEX™: Phase 1 Study in Cancer Patients

NCT01222637

Conditions
Solid Tumors
Locations
  • Glycotope Investigational Site Hamburg, Germany
  • Glycotope Investigational Site Heidelberg, Germany
  • Glycotope Investigational Site Milan, Italy
  • Glycotope Investigational Site Milan, Italy
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors

NCT03264066

Conditions
Solid Tumors
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Kansas City - Menorah Medical Center Kansas City, Kansas, United States
  • Memorial Sloan-Kettering Cancer Center Commack, New York, United States
  • Memorial Sloan Kettering - Basking Ridge New York, United States
View all 19 locations
View Trial Details
Completed

TrasGEX™: Phase 1 Study in Cancer Patients

NCT01409343

Conditions
Solid Tumors
Locations
  • Glycotope Investigational Site Graz, Austria
  • Glycotope Investigational Site Innsbruck, Austria
  • Glycotope Investigational Site Hamburg, Germany
  • Glycotope Investigational Site Milan, Italy
View Trial Details
Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

NCT01327612

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
Locations
  • Research Site Duarte, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
View Trial Details
Completed

Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas

NCT02740270

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site New York, United States
  • Novartis Investigative Site Houston, Texas, United States
View Trial Details

Related conditions